- Tularik, Amgen discover and develop cancer therapeutics
- Tularik signs GPCR alliance with Sankyo
- Tularik and Japan Tobacco sign their third alliance
- Medarex, Tularik develop antibodies to treat cancer
- Tularik buys Amplicon in all-stock deal
- Amgen buys Immunex in $17.9bn cash and stock deal
- Cytokinetics licenses mitotic kinesins to GSK; ends
- GSK, Exelixis co-develop, -promote therapeutics; terminated
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.